Definitive Contract HHSO100201600031C
Award Date
8/29/16
Potential Completion Date
9/30/24
Potential Value
$79M
Awardee
Merck Sharp & Dohme LLC
Ultimate Awardee
Schering Plough Corporation
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Ames, IA 50010, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $111,268,952.26 cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Merck Sharp & Dohme LLC (doing business as Merck), a for-profit pharmaceutical manufacturer. The contract is for the manufacturing and development of the RVSV-ZEBOV vaccine, a critical medical countermeasure. It does not have a set-aside designation. Merck also holds several significant indefinite delivery vehicles...
This is a $174,606,943.00 definitive contract awarded to Merck Sharp & Dohme LLC, doing business as Merck, by the Office of the Assistant Secretary for Preparedness and Response (ASPR) for the procurement of the ERVEBO vaccine. Merck is a major pharmaceutical manufacturer that provides a wide range of vaccines, drugs, and medical countermeasures to support federal healthcare programs. The contract does not have a set-aside designation. It is part of Merck's broader indefinite delivery...
This is a $291,370,929.00 cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Merck Sharp & Dohme LLC, a subsidiary of Schering Plough Corporation and major pharmaceutical manufacturer. The contract has a period of performance through September 27, 2027 and is not set aside for any specific business category. Merck has been awarded numerous prime contracts, subcontracts, and indefinite delivery vehicles (IDVs) by...
This federal contract award, valued at $97,091.53, was issued by the Office of the Assistant Secretary for Administration (a civilian agency) to Merck Sharp & Dohme LLC, doing business as Merck, for the delivery of MERCK VACCINES FOR STOCK. The contract is a Firm Fixed Price Delivery Order without a set-aside designation. Merck is a major pharmaceutical manufacturer and supplier to the U.S. federal government, providing a wide range of vaccines, drugs, and medical countermeasures to...
This is a delivery order contract awarded to Merck Sharp & Dohme LLC, doing business as Merck, by the Department of Health and Human Services Office of the Assistant Secretary for Administration. The contract is for the provision of vaccines, with a potential value of $124,256.21. The contract is not set-aside and falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). As a leading manufacturer of pharmaceuticals and vaccines, Merck has received numerous federal...
This federal contract award is for the delivery of Merck vaccines to the U.S. government. The contract was awarded by the Office of the Assistant Secretary for Administration, a civilian agency, to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract has a firm fixed price of $301,818.00 and a completion date of April 28, 2015. The award is not associated with a set-aside designation. It appears to be part of Merck's broader federal supply...
<p>This is a $81,976,383.00 definitive, cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Public Health Vaccines LLC, a self-certified small disadvantaged business, for the advanced research and development of an RVSV-MARV vaccine. The contract has an ultimate completion date of August 31, 2027 and was awarded on February 1, 2019. The contract does not have a set-aside designation.</p>
This is a federal contract award to Merck Sharp & Dohme LLC, doing business as Merck, by the Department of Health and Human Services Centers for Disease Control and Prevention. The contract is valued at $2,296,282,738.69 and is for the delivery of vaccines under the Vaccines for Children program. The contract is a definitive contract with a firm fixed price and has a completion date of March 31, 2018. Merck, a for-profit manufacturer of goods, is the prime contractor for this award, which...
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the U.S. Department of Health and Human Services, to Profectus Biosciences, Inc., a small business contractor. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, with a ceiling value of $7,524,330.27 and a period of performance through November 30, 2016. The contract is for the GMP (Good Manufacturing Practice) manufacture of the...
This is a $95,575.90 firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Administration (a civilian agency) to Merck Sharp & Dohme LLC (doing business as Merck), a major pharmaceutical manufacturer, for the supply of vaccines. The award is under Merck's Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) and is not a set-aside contract. Merck, a subsidiary of Schering Plough Corporation, has received numerous federal contract awards...